Leverkusen, Germany

Yolanda Cancho-Grande

This inventor holds 6 USPTO granted patents and 2 published patent applications and 3 EPO patents. Top assignees: Aicuris Gmbh + Co. Kg., Bayer Pharma Aktiengesellschaft, Elanco Animal Health Gmbh. Active years: 2008-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yolanda Cancho-Grande. Retrieved from https://idiyas.com/inventor/yolanda-cancho-grande-o06kis3d

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 6 

% Patents Active = 33.3

 

Average Co-Inventor Count = 11.1

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2008-2026

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Yolanda Cancho-Grande: Innovator in Pharmaceutical Chemistry

Introduction

Yolanda Cancho-Grande is a prominent inventor based in Leverkusen, Germany. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds for medical applications. With a total of five patents to her name, her work focuses on addressing critical health issues.

Latest Patents

Yolanda's latest patents include innovative compounds known as (aza)pyridopyrazolopyrimidinones and indazolopyrimidinones. These compounds are designed for use in the treatment and prophylaxis of various diseases, especially those associated with acute and recurrent bleeding. The applications of her inventions are particularly relevant for patients with hereditary or acquired bleeding disorders. The compounds can be utilized in medical interventions related to conditions such as menorrhagia, postpartum hemorrhage, hemorrhagic shock, trauma, surgery, transplantation, stroke, liver diseases, hereditary angioedema, nosebleed, and synovitis, as well as cartilage damage following hemarthrosis.

Career Highlights

Throughout her career, Yolanda has worked with notable companies in the pharmaceutical industry, including Aicuris GmbH & Co. KG and Bayer Pharma Aktiengesellschaft. Her expertise and innovative approach have positioned her as a key figure in her field.

Collaborations

Yolanda has collaborated with esteemed colleagues such as Joachim Schuhmacher and Rainer Endermann, contributing to the advancement of pharmaceutical research and development.

Conclusion

Yolanda Cancho-Grande's work exemplifies the impact of innovation in the pharmaceutical industry. Her contributions to the development of new medical compounds are vital for improving patient care and treatment outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…